During the past decade, CIMEL conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CIMEL" #1 sponsor was "Bayer" with 4 trials, followed by "Gilead Sciences" with 2 trials sponsored, "Mannkind Corporation" with 2 trials sponsored, "Bio Sidus SA" with 1 trials sponsored and "CymaBay Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CIMEL" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CIMEL" are "Hypertension" (2 trials), "Anemia of Chronic Kidney Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetes, Type I" (1 trials). Many other conditions were trialed in "CIMEL" in a lesser frequency.

Most popular intervention types in "CIMEL" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Finerenone (BAY94-8862)" (3 trials), "Placebo" (3 trials), "Darusentan" (2 trials), "Technosphere Insulin" (2 trials) and "Active comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "CIMEL" are 11 trials for "All" genders.

Currently, there are NaN active trials in "CIMEL". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CIMEL, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CIMEL, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".